Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 849

1.

Atrial fibrillation associated with systemic lupus erythematosus and use of methylprednisolone.

Aslam AK, Vasavada BC, Sacchi TJ, Khan IA.

Am J Ther. 2001 Jul-Aug;8(4):303-5.

PMID:
11441330
2.

Atrial fibrillation following methylprednisolone pulse therapy.

Ueda N, Yoshikawa T, Chihara M, Kawaguchi S, Niinomi Y, Yasaki T.

Pediatr Nephrol. 1988 Jan;2(1):29-31.

PMID:
3152997
3.

Cardiovascular manifestations of systemic lupus erythematosus: current perspective.

Ansari A, Larson PH, Bates HD.

Prog Cardiovasc Dis. 1985 May-Jun;27(6):421-34. Review.

PMID:
2860699
4.

Recurrent atrial fibrillation after high-dose methylprednisolone therapy in a girl with lupus-associated hemophagocytic syndrome.

Yamamura K, Ohga S, Nishiyama K, Doi T, Tsutsumi Y, Ikeda K, Fujishima A, Takada H, Hara T.

Lupus. 2011 Jul;20(8):871-5. doi: 10.1177/0961203310392429. Epub 2011 Mar 17.

PMID:
21415254
6.
7.

Central nervous system manifestations after pulse therapy for systemic lupus erythematosus.

Ayoub WT, Torretti D, Harrington TM.

Arthritis Rheum. 1983 Jun;26(6):809-10. No abstract available.

PMID:
6860385
8.

A case of cerebral systemic lupus erythematosus treated with methylprednisolone pulse therapy.

Price J, Klestov A, Beacham B, Roberts C.

Aust N Z J Psychiatry. 1985 Jun;19(2):184-8.

PMID:
3863609
10.

Reversible parkinsonian syndrome in systemic and brain vasculitis.

Fabiani G, Teive HA, Germiniani FM, Sá DS, Werneck LC.

Mov Disord. 2002 May;17(3):601-4.

PMID:
12112215
11.

[Vascular hyperfragility in systemic lupus erythematosus treated with low doses of cortisone].

Longo F, Di Leo G, Lepore L, Pennesi M.

Pediatr Med Chir. 1995 Nov-Dec;17(6):535-7. Italian.

PMID:
8668590
12.

Adverse reaction to prednisone in a patient with systemic lupus erythematosus.

Lew DB, Higgins GC, Skinner RB, Snider MD, Myers LK.

Pediatr Dermatol. 1999 Mar-Apr;16(2):146-50.

PMID:
10337682
13.

Methylprednisolone in systemic lupus erythematosus.

Howe HS, Boey ML, Feng PH.

Singapore Med J. 1990 Feb;31(1):18-21.

PMID:
2333537
14.

Sinus node dysfunction as an initial presentation of adult systemic lupus erythematosus.

Lin Y, Liou YM, Chen JY, Chang KC.

Lupus. 2011 Oct;20(10):1072-5. doi: 10.1177/0961203310396747. Epub 2011 Apr 8.

PMID:
21478288
15.
16.

Atrial fibrillation due to oral methylprednisolone in a patient with membranoproliferative glomerulonephritis.

Dogukan A, Ilkay E, Poyrazoglu OK, Gunal AI, Ozgen M, Pekdemir M.

Acta Medica (Hradec Kralove). 2008;51(1):63-4.

17.

High-dose intravenous methylprednisolone therapy associated with osteonecrosis in patients with systemic lupus erythematosus.

Massardo L, Jacobelli S, Leissner M, González M, Villarroel L, Rivero S.

Lupus. 1992 Dec;1(6):401-5.

PMID:
1304409
18.

Intravenous methylprednisolone in the treatment of systemic lupus erythematosus.

Mackworth-Young CG, Morgan SH, Hughes GR.

Scand J Rheumatol Suppl. 1984;54:16-8. No abstract available.

PMID:
6592750
19.

Methylprednisolone pulse therapy for nonrenal lupus erythematosus.

Eyanson S, Passo MH, Aldo-Benson MA, Benson MD.

Ann Rheum Dis. 1980 Aug;39(4):377-80.

20.

GI vasculitis associated with systemic lupus erythematosus.

Lee CK, Lee TH, Lee SH, Chung IK, Park SH, Kim HS, Kim SJ.

Gastrointest Endosc. 2010 Sep;72(3):618-9. doi: 10.1016/j.gie.2010.02.033. Epub 2010 Jun 11. No abstract available.

PMID:
20541196
Items per page

Supplemental Content

Write to the Help Desk